Monsanto and ToolGen Announce Global Licensing Agreement on CRISPR Platform, Underscore the Benefits of Innovation for Farmers
Go back to Monsanto and ToolGen Announce Global Licensing Agreement on CRISPR Platform, Underscore the Benefits of Innovation for Farmers| Monsanto Company (NASDAQ: MON) | Delayed: 10.07 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.07 | 52 Week High | $114.26 | |||
| Open | $249.00 | 52 Week Low | $83.73 | |||
| Day High | $10.07 | P/E | 2.17 | |||
| Day Low | $10.07 | EPS | $4.63 | |||
| Volume | 1,230,913 | |||||
